These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. A new therapeutic approach of nephrotic syndrome associated with focal segmental glomerulosclerosis. Futrakul P Int J Pediatr Nephrol; 1980 Mar; 1(1):18-21. PubMed ID: 7343523 [TBL] [Abstract][Full Text] [Related]
27. Two distinct FSGS lesions caused by distinct etiology confirmed in a single patient in pre- and post-transplantation. Ito Y; Nishi S; Imai N; Narita I; Gejyo F; Saito K; Nakagawa Y; Tasaki M; Takahashi K Clin Transplant; 2010 Jul; 24 Suppl 22():54-9. PubMed ID: 20590696 [TBL] [Abstract][Full Text] [Related]
28. A case report of nephrotic syndrome due to collapsing focal segmental glomerulosclerosis treated with low-density lipoprotein apheresis. Miyazono M; Tomiyoshi Y; Kishi T; Ikeda Y; Sakemi T; Sanai T; Node K Ther Apher Dial; 2008 Aug; 12(4):333-6. PubMed ID: 18789122 [TBL] [Abstract][Full Text] [Related]
29. Acute lymphoblastic leukemia in a child with nephrotic syndrome. Bhatia M; Kher K; Minniti CP Pediatr Nephrol; 2004 Nov; 19(11):1290-3. PubMed ID: 15372224 [TBL] [Abstract][Full Text] [Related]
30. Effects of cyclosporine, azathioprine and prednisone on Kimura's disease and focal segmental glomerulosclerosis in renal transplant patients. Senel MF; Van Buren CT; Etheridge WB; Barcenas C; Jammal C; Kahan BD Clin Nephrol; 1996 Jan; 45(1):18-21. PubMed ID: 8616952 [TBL] [Abstract][Full Text] [Related]
31. The long-term results of pediatric patients with primary focal and segmental glomerulosclerosis. Sozeri B; Mir S; Mutlubas F; Sen S Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):87-92. PubMed ID: 20061699 [TBL] [Abstract][Full Text] [Related]
32. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal. Geary DF; Farine M; Thorner P; Baumal R Clin Nephrol; 1984 Sep; 22(3):109-13. PubMed ID: 6488594 [TBL] [Abstract][Full Text] [Related]
33. Glomerular growth under cyclosporine treatment in childhood nephrotic syndrome. Jeong HJ; Kim JH; Kim PK; Choi IJ Clin Nephrol; 2001 Apr; 55(4):289-96. PubMed ID: 11334314 [TBL] [Abstract][Full Text] [Related]
34. Posterior reversible encephalopathy syndrome in malignant hypertension secondary to focal segmental glomerulosclerosis. Abdullah HM; Ullah W; Ahmad E; Anwer F BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27535734 [TBL] [Abstract][Full Text] [Related]
36. [Reversible posterior leukoencephalopathy syndrome in patients with immunosuppressive treatment: report of four cases]. Hernández Ch M; Núñez F A; Mesa L T; Escobar H R; Barriga C F; Huete L I Rev Med Chil; 2008 Jan; 136(1):93-8. PubMed ID: 18483659 [TBL] [Abstract][Full Text] [Related]
37. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature. Peters HP; van de Kar NC; Wetzels JF Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266 [TBL] [Abstract][Full Text] [Related]
39. [Indications for cyclosporin in the treatment of idiopathic nephrotic syndrome in adults]. Zietse R; Weimar W Ned Tijdschr Geneeskd; 1992 Sep; 136(36):1749-53. PubMed ID: 1407123 [No Abstract] [Full Text] [Related]
40. Blood level of cyclosporin [correction of cyclospolin] during LDL-apheresis in nephrotic syndrome patients. Nakajima F; Shibahara N; Ijiri Y; Ashida A; Ueda H; Katsuoka Y J Clin Apher; 1999; 14(4):193-4. PubMed ID: 10611632 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]